@FiercePharma: Otsuka prepares to roll out two-drug combo for colorectal cancer. FiercePharmaMarketing story | Follow @FiercePharma
@EricPFierce: ICYMI: Novo to build a $78M insulin pen plant in Iran. FiercePharmaManufacturing story | Follow @EricPFierce
> Amgen ($AMGN) and Allergan ($AGN) said a late-stage study showed their biosimilar candidate of Roche ($RHHBY) blockbuster Avastin was as effective as the original in lung cancer. Story
> ViiV Healthcare says a data from a Phase IIIb/IV study met the endpoint in patients with suppressed HIV when they switched to its once daily Triumeq from an antiretroviral therapy. Release
> Depomed Wednesday reported a decision from patent regulators that it said will help it in its patent-infringement lawsuits against Endo Pharmaceuticals ($ENDP) and Purdue Pharma and their competing painkillers. Report
> U.S. Rep. Elijah E. Cummings is asking the House to hold a hearing with Martin Shkreli, whose company Turing Pharma recently jacked up the price by 5000% of a pill whose users tend to be AIDS sufferers and cancer patients. Release
> England's price watchdog NICE has recommended approval of Daiichi Sankyo's bloodthinner Lixiana to prevent blood clots in adult patients with a certain heart rhythm disorder. Story
Medical Device News
@FierceMedDev: ICYMI: St. Jude nabs CE mark for Infinity DBS for movement disorders, awaits U.S. launch before year end. Article | Follow @FierceMedDev
@VarunSaxena2: ICYMI from FierceBiotech: Should Martin Shkreli be allowed to play the Good Samaritan defense? Commentary | Follow @VarunSaxena2
@EmilyWFierce: Human Longevity joins with South African insurer for $250 exome sequencing service. FierceDiagnostics article | Follow @EmilyWFierce
> CliniCloud gets $5M seed round to launch connected medical kit at Best Buy. News
> Institute of Medicine makes suggestions for improving accuracy of medical diagnoses. Item
> Four key medical device recalls of 2015. Report
Biotech News
@FierceBiotech: FierceBiotech Radio with @JohnCFierce on Turing Pharma, Martin Shkreli and the magic of Twitter. More | Follow @FierceBiotech
@JohnCFierce: These Twitter controversies are intense. On CNN, Sky News, CBC and other radio shows to discuss being called a moron. Cheers. | Follow @JohnCFierce
@DamianFierce: The best thing about ABC's exclusive Shkreli story was that NBC ran it 15 minutes earlier. | Follow @DamianFierce
> Amgen and Allergan clear Phase III with an Avastin biosimilar, looking to unseat a blockbuster. More
> Scholar Rock hopes to one-up pharma titans with a muscle-building drug. News
> OncoGenex's drug misses the mark in pancreatic cancer. Story
Biotech Research News
> Uppsala's 'smart' robot tests new cancer drug combos. News
> Epigenomic combo shows promise in mouse model of pancreatic cancer. Story
> An arthritis drug demos potential to help reverse Alzheimer's disease. More
> Experimental drug amps up Afinitor's punch against pancreatic cancer. Article
> Imperial team targets a key culprit involved in Parkinson's. News
Diagnostics News
> Roche's influenza A and B tests get federal permission to be used at the point-of-care. Story
> LabCorp, China's Fosun Pharma, lead Asia-heavy $15B investment in Ativa Medical. More
> Rumor: Private equity owners looking to sell Swiss diagnostics player Unilabs for $1.7B. Article
> Human Longevity joins with South African insurer for $250 exome sequencing service. News
> Sequenom appoints new CEO amid diversification. Story
Pharma Marketing News
> Emmy co-host Mario Lopez spotlights Valeant's Jublia on the red carpet. News
> Fretting about potential Humira pain for AbbVie? Take heart in potential cost cuts. Story
> Apple's ad blocking heats up debate, but what does it mean for pharma? Article
> IMS Health finds mHealth mobile app 'prescriptions' on the rise. Story
> Otsuka prepares to roll out two-drug combo for colorectal cancer. Item
And Finally... Arkansas intends to go ahead and use for lethal injection a Sun Pharma drug despite the company's objection. Story